BRD4 and Miyoshi myopathy: Recent studies have recognized the important role of the BET family member BRD4 at super enhancer regions involved in the regulation of specific oncogenes in different cancers, including MM [2, 4, 33–37], and highlighted the feasibility of blocking its function using BETi.